You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR TETRACAINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for tetracaine hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00107822 ↗ Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children Completed ZARS Pharma Inc. Phase 3 2005-04-01 The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in children. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.
NCT00107835 ↗ Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults Completed ZARS Pharma Inc. Phase 3 2005-05-01 The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in adults. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.
NCT00110253 ↗ Duration of Skin Numbing Effect Created by the S-Caine™ Peel Completed ZARS Pharma Inc. Phase 3 2005-06-01 S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a new skin numbing cream made of lidocaine and tetracaine. The purpose of this study is to evaluate and measure the length of time the S-Caine Peel numbs the skin, when applied for 30 and 60 minutes.
NCT00110734 ↗ S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults Completed ZARS Pharma Inc. Phase 3 1969-12-31 There is pain associated with laser-assisted tattoo removal. For this reason, some form of anesthesia is commonly used to eliminate or minimize the pain. This anesthesia is usually a topical local anesthetic cream or ointment spread over the skin. The purpose of this study is to further estimate the effectiveness of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) for treating pain during laser-assisted tattoo removal.
NCT00110747 ↗ S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults Completed ZARS Pharma Inc. Phase 3 2005-06-01 Lasers are used for non-ablative resurfacing of facial rhytides, atrophic scars, and a variety of epidermal and dermal lesions. Pain associated with the non-ablative laser treatment has been described as moderate to severe. For this reason, local anesthesia is commonly used to eliminate or minimize the pain. S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate if S-Caine Peel is effective in providing topical local dermal anesthesia for non-ablative facial laser resurfacing in adults.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for tetracaine hydrochloride

Condition Name

Condition Name for tetracaine hydrochloride
Intervention Trials
Pain 20
Anesthesia 9
Healthy 4
Corneal Abrasion 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for tetracaine hydrochloride
Intervention Trials
Lacerations 6
Pain, Postoperative 4
Cataract 3
Macular Degeneration 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for tetracaine hydrochloride

Trials by Country

Trials by Country for tetracaine hydrochloride
Location Trials
United States 74
Canada 6
China 5
Italy 4
Spain 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for tetracaine hydrochloride
Location Trials
Texas 9
New York 9
Florida 7
Pennsylvania 5
Utah 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for tetracaine hydrochloride

Clinical Trial Phase

Clinical Trial Phase for tetracaine hydrochloride
Clinical Trial Phase Trials
Phase 4 21
Phase 3 16
Phase 2/Phase 3 3
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for tetracaine hydrochloride
Clinical Trial Phase Trials
Completed 65
Unknown status 10
Withdrawn 7
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for tetracaine hydrochloride

Sponsor Name

Sponsor Name for tetracaine hydrochloride
Sponsor Trials
ZARS Pharma Inc. 16
Rho, Inc. 7
St. Renatus, LLC 7
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for tetracaine hydrochloride
Sponsor Trials
Other 77
Industry 55
U.S. Fed 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.